Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveA phase Ib/II study to assess the safety and efficacy of PM8002/BNT327 in combination with nab-paclitaxel for first-line treatment of locally advanced or metastatic triple-negative breast cancer
Wu, J.; Zhang, J.; Tong, Z.; Zhang, Q.; Wang, Y.; Cheng, Q.; Chen, X.; Li, Z.; Yin, Y.; Du, Y.; Meng, Y.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveFinal analysis of PUFFIN: A phase III, randomised double-blind, placebo (Pla)-controlled study of pertuzumab, trastuzumab and docetaxel (PHD) for Chinese patients (pts) with previously untreated HER2-positive locally recurrent or metastatic breast cancer (LR/MBC)
Xu, B.; Li, W.; Zhang, Q.; Li, Q.; Wang, X.; Li, H.; Sun, T.; Yin, Y.; Zheng, H.; Feng, J.; Zhu, H.; Siddiqui, A.; Macharia, H. N.; Knott, A.
Share
Save
Share
Save
Share
Save